Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate. [electronic resource]
Producer: 20150512Description: E487-92 p. digitalISSN:- 1945-7197
- Aged
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bone Density -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Denosumab
- Diphosphonates -- therapeutic use
- Drug Substitution
- Etidronic Acid -- analogs & derivatives
- Female
- Humans
- Ibandronic Acid
- Middle Aged
- Osteoporosis, Postmenopausal -- drug therapy
- Patient Satisfaction
- Risedronic Acid
- Treatment Outcome
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.